Here, we have demonstrated that the sigma-2 receptor-specific ligand, SV-119, potentiates cell death when combined with conventional chemotherapies without appreciable toxicity in model pancreatic adenocarcinoma. The gene discussed is TMEM97; the disease is pancreatic adenocarcinoma.